Pay in 4 interest-free payments of $5.82 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
Given its significant preclinical activity and oral bioavailability, GSBR-1290 has the potential to become a differentiated treatment option without the need for dietary restrictions or concurrent therapeutic regimens
Given the regenerative potential of hMSC, understanding how GLP-1-RA affect these cells is crucial for determining further implications of these drugs on tissue homeostasis and metabolic health
doi: 10.1016/j.cmet.2017.04.001 63
Learn more about lifestyle changes that protect the kidneys
European Teratology Information Services Study (BMJ 2024) Design: Prospective observational cohort Sample: 168 GLP-1 RA-exposed pregnancies, compared with diabetic and obese reference groups Findings: Major birth defect rates: 2.6% (GLP-1 RA) vs
US$ 28.17
US$ 25.98
US$ 23.21
